Search Results

There are 19343 results for: content related to: A multicenter survey of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan

  1. You have free access to this content
    Meta-analysis: re-treatment of genotype I hepatitis C nonresponders and relapsers after failing interferon and ribavirin combination therapy

    Alimentary Pharmacology & Therapeutics

    Volume 32, Issue 8, October 2010, Pages: 969–983, A. G. Singal, A. K. Waljee, M. Shiffman, B. R. Bacon and P. S. Schoenfeld

    Version of Record online : 15 AUG 2010, DOI: 10.1111/j.1365-2036.2010.04427.x

  2. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  3. Favorable factors for re-treatment with pegylated interferon α2a plus ribavirin in patients with high viral loads of genotype 1 hepatitis C virus

    Hepatology Research

    Volume 41, Issue 12, December 2011, Pages: 1169–1177, Akihiro Tamori, Kiyohide Kioka, Osamu Kurai, Hiroki Sakaguchi, Masaru Enomoto, Hideki Fujii, Sawako Kobayashi, Shuji Iwai, Hiroyasu Morikawa, Seiko Yamaguchi, Yasuko Kawasaki, Hiroko Oka, Yasuhito Tanaka and Norifumi Kawada

    Version of Record online : 26 SEP 2011, DOI: 10.1111/j.1872-034X.2011.00887.x

  4. You have free access to this content
    Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 714A–807A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28228

  5. Hepatitis C

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 15 SEP 2006, DOI: 10.1002/9780470041000.cedt033

  6. Clinical utility of host genetic IL-28B variants in hepatitis C virus genotype 1 Asian patients retreated with pegylated interferon plus ribavirin

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue 9, September 2013, Pages: 1515–1520, Chung-Feng Huang, Ming-Lun Yeh, Meng-Hsuan Hsieh, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Liang-Yen Wang, Jee-Fu Huang, Suh-Hang Hank Juo, Yi-Ching Lin, Chia-Yen Dai, Wan-Long Chuang and Ming-Lung Yu

    Version of Record online : 22 AUG 2013, DOI: 10.1111/jgh.12211

  7. Individualisation of antiviral therapy for chronic hepatitis C

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 7, July 2010, Pages: 1206–1216, Narci C Teoh, Geoffrey C Farrell and Henry L-Y Chan

    Version of Record online : 24 MAY 2010, DOI: 10.1111/j.1440-1746.2010.06392.x

  8. Management of hepatitis C; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009)

    Hepatology Research

    Volume 40, Issue 4, April 2010, Pages: 347–368, Izumi Namiki, Shuhei Nishiguchi, Keisuke Hino, Fumitaka Suzuki, Hiromitsu Kumada, Yoshihito Itoh, Yusuhiro Asahina, Akihiro Tamori, Naoki Hiramatsu, Norio Hayashi and Masatoshi Kudo

    Version of Record online : 29 MAR 2010, DOI: 10.1111/j.1872-034X.2010.00642.x

  9. Randomized trial of three different regimens for 24 weeks for re-treatment of chronic hepatitis C patients who failed to respond to interferon-α monotherapy in Taiwan

    Liver International

    Volume 24, Issue 6, December 2004, Pages: 595–602, Wan-Long Chuang, Chia-Yen Dai, Shinn-Cherng Chen, Li-Po Lee, Zu-Yau Lin, Ming-Yuh Hsieh, Liang-Yen Wang, Ming-Lung Yu and Wen-Yu Chang

    Version of Record online : 26 NOV 2004, DOI: 10.1111/j.1478-3231.2004.0954.x

  10. You have free access to this content
    Guidelines for the Management of Hepatitis C Virus Infection

    Hepatology Research

    Volume 43, Issue 1, January 2013, Pages: 1–34, Editors of the Drafting Committee for Hepatitis Management Guidelines: The Japan Society of Hepatology

    Version of Record online : 18 JAN 2013, DOI: 10.1111/hepr.12020

  11. You have free access to this content
    Abstracts 210 to 431

    Hepatology

    Volume 46, Issue S1, October 2007, Pages: 331A–430A,

    Version of Record online : 19 SEP 2007, DOI: 10.1002/hep.22017

  12. Management of chronic hepatitis C patients who have relapsed or not responded to pegylated interferon alfa plus ribavirin

    Journal of Viral Hepatitis

    Volume 16, Issue 12, December 2009, Pages: 833–843, D. T. Dieterich, M. Rizzetto and M. P. Manns

    Version of Record online : 2 NOV 2009, DOI: 10.1111/j.1365-2893.2009.01218.x

  13. Indices of initial hepatitis C virus RNA reduction rate to predict efficacy of interferon-beta followed by peginterferon plus ribavirin for genotype 1b high viral load

    Hepatology Research

    Volume 44, Issue 7, July 2014, Pages: 728–734, Hiroaki Okushin, Takeharu Yamamoto, Hiroshi Kishida, Kazuhiko Morii and Koichi Uesaka

    Version of Record online : 11 JUL 2013, DOI: 10.1111/hepr.12182

  14. You have free access to this content
    Determinants of relapse after a short (12 weeks) course of antiviral therapy and re-treatment efficacy of a prolonged course in patients with chronic hepatitis C virus genotype 2 or 3 infection

    Hepatology

    Volume 49, Issue 2, February 2009, Pages: 358–363, Alessandra Mangia, Nicola Minerva, Donato Bacca, Raffaele Cozzolongo, Ernesto Agostinacchio, Fernando Sogari, Gaetano Scotto, Francesco Vinelli, Giovanni Luciano Ricci, Mario Romano, Vito Carretta, Daniela Petruzzellis and Angelo Andriulli

    Version of Record online : 9 OCT 2008, DOI: 10.1002/hep.22679

  15. Re-treatment of chronic hepatitis C patients after relapse: efficacy of peginterferon-alpha-2a (40 kDa) and ribavirin

    Journal of Viral Hepatitis

    Volume 13, Issue 7, July 2006, Pages: 435–440, C. Berg, F. L. Goncales Jr, D. E. Bernstein, H. Sette Jr, J. Rasenack, M. Diago, D. M. Jensen, P. Graham and G. Cooksley

    Version of Record online : 26 APR 2006, DOI: 10.1111/j.1365-2893.2006.00727.x

  16. You have free access to this content
    Review article: the role of rapid virological response in determining treatment duration for chronic hepatitis C

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 12, June 2010, Pages: 1251–1267, F. F. POORDAD

    Version of Record online : 17 MAR 2010, DOI: 10.1111/j.1365-2036.2010.04300.x

  17. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Version of Record online : 1 OCT 2012, DOI: 10.1002/hep.26040

  18. You have full text access to this OnlineOpen article
    Expert opinion on the treatment of patients with chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 16, Issue 2, February 2009, Pages: 75–90, S. Zeuzem, T. Berg, B. Moeller, H. Hinrichsen, S. Mauss, H. Wedemeyer, C. Sarrazin, D. Hueppe, E. Zehnter and M. P. Manns

    Version of Record online : 28 AUG 2008, DOI: 10.1111/j.1365-2893.2008.01012.x

  19. You have free access to this content
    Response-guided peg-interferon plus ribavirin treatment duration in chronic hepatitis C: Meta-analyses of randomized, controlled trials and implications for the future

    Hepatology

    Volume 54, Issue 3, 2 September 2011, Pages: 789–800, Vincent Di Martino, Carine Richou, Jean-Paul Cervoni, Jose M. Sanchez-Tapias, Donald M. Jensen, Alessandra Mangia, Maria Buti, Frances Sheppard, Peter Ferenci and Thierry Thévenot

    Version of Record online : 19 JUL 2011, DOI: 10.1002/hep.24480

  20. You have full text access to this OnlineOpen article
    Efficacy and safety of telaprevir, a new protease inhibitor, for difficult-to-treat patients with genotype 1 chronic hepatitis C

    Journal of Viral Hepatitis

    Volume 19, Issue 2, February 2012, Pages: e134–e142, N. Hayashi, T. Okanoue, H. Tsubouchi, J. Toyota, K. Chayama and H. Kumada

    Version of Record online : 8 NOV 2011, DOI: 10.1111/j.1365-2893.2011.01528.x